These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 31743041)

  • 1. Rapid hepatic metabolism blunts the endocrine action of portally infused GLP-1 in male rats.
    Aulinger BA; Perabo M; Seeley RJ; Parhofer KG; D'Alessio DA
    Am J Physiol Endocrinol Metab; 2020 Feb; 318(2):E189-E197. PubMed ID: 31743041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraportal GLP-1 stimulates insulin secretion predominantly through the hepatoportal-pancreatic vagal reflex pathways.
    Nishizawa M; Nakabayashi H; Uehara K; Nakagawa A; Uchida K; Koya D
    Am J Physiol Endocrinol Metab; 2013 Aug; 305(3):E376-87. PubMed ID: 23715725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The insulinotropic effect of exogenous glucagon-like peptide-1 is not affected by acute vagotomy in anaesthetized pigs.
    Veedfald S; Hansen M; Christensen LW; Larsen SA; Hjøllund KR; Plamboeck A; Hartmann B; Deacon CF; Holst JJ
    Exp Physiol; 2016 Jul; 101(7):895-912. PubMed ID: 27027735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucagon-like peptide-1 (GLP-1) receptors expressed on nerve terminals in the portal vein mediate the effects of endogenous GLP-1 on glucose tolerance in rats.
    Vahl TP; Tauchi M; Durler TS; Elfers EE; Fernandes TM; Bitner RD; Ellis KS; Woods SC; Seeley RJ; Herman JP; D'Alessio DA
    Endocrinology; 2007 Oct; 148(10):4965-73. PubMed ID: 17584962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of GLP-1 infusion in the hepatic portal region on food intake.
    Kim DH; D'Alessio DA; Woods SC; Seeley RJ
    Regul Pept; 2009 Jun; 155(1-3):110-4. PubMed ID: 19289143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of dipeptidyl peptidase-4 by vildagliptin during glucagon-like Peptide 1 infusion increases liver glucose uptake in the conscious dog.
    Edgerton DS; Johnson KM; Neal DW; Scott M; Hobbs CH; Zhang X; Duttaroy A; Cherrington AD
    Diabetes; 2009 Jan; 58(1):243-9. PubMed ID: 18840785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Portal GLP-1 administration in rats augments the insulin response to glucose via neuronal mechanisms.
    Balkan B; Li X
    Am J Physiol Regul Integr Comp Physiol; 2000 Oct; 279(4):R1449-54. PubMed ID: 11004015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GLP-1 Receptor Blockade Reduces Stimulated Insulin Secretion in Fasted Subjects With Low Circulating GLP-1.
    Gray SM; Hoselton AL; Krishna R; Slentz CA; D'Alessio DA
    J Clin Endocrinol Metab; 2022 Aug; 107(9):2500-2510. PubMed ID: 35775723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraportal GLP-1 infusion increases nonhepatic glucose utilization without changing pancreatic hormone levels.
    Johnson KM; Edgerton DS; Rodewald T; Scott M; Farmer B; Neal D; Cherrington AD
    Am J Physiol Endocrinol Metab; 2007 Oct; 293(4):E1085-91. PubMed ID: 17684104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The entero-insular axis: implications for human metabolism.
    Ranganath LR
    Clin Chem Lab Med; 2008; 46(1):43-56. PubMed ID: 18020966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissociated effects of glucose-dependent insulinotropic polypeptide vs glucagon-like peptide-1 on beta-cell secretion and insulin clearance in mice.
    Pacini G; Thomaseth K; Ahrén B
    Metabolism; 2010 Jul; 59(7):988-92. PubMed ID: 20153002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular Sites and Mechanisms Linking Reduction of Dipeptidyl Peptidase-4 Activity to Control of Incretin Hormone Action and Glucose Homeostasis.
    Mulvihill EE; Varin EM; Gladanac B; Campbell JE; Ussher JR; Baggio LL; Yusta B; Ayala J; Burmeister MA; Matthews D; Bang KWA; Ayala JE; Drucker DJ
    Cell Metab; 2017 Jan; 25(1):152-165. PubMed ID: 27839908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GLP-1: what is known, new and controversial in 2010?
    Burcelin R; Dejager S
    Diabetes Metab; 2010 Dec; 36(6 Pt 1):503-9. PubMed ID: 21075654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of the Incretin Hormones on the Endocrine Pancreas in End-Stage Renal Disease.
    Jørgensen MB; Idorn T; Rydahl C; Hansen HP; Bressendorff I; Brandi L; Wewer Albrechtsen NJ; van Hall G; Hartmann B; Holst JJ; Knop FK; Hornum M; Feldt-Rasmussen B
    J Clin Endocrinol Metab; 2020 Jan; 105(1):. PubMed ID: 31608934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biophysical and pharmacological properties of glucagon-like peptide-1 in rats under isoflurane anesthesia.
    Kawano T; Tanaka K; Chi H; Eguchi S; Yamazaki F; Kitamura S; Kumagai N; Yokoyama M
    Anesth Analg; 2012 Jul; 115(1):62-9. PubMed ID: 22504208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incretins and Their Endocrine and Metabolic Functions.
    Seufert J
    Endocr Dev; 2017; 32():38-48. PubMed ID: 28873383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of glucagon-like peptide-1 on beta- and alpha-cell function in isolated islet and whole pancreas transplant recipients.
    Rickels MR; Mueller R; Markmann JF; Naji A
    J Clin Endocrinol Metab; 2009 Jan; 94(1):181-9. PubMed ID: 18957498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired incretin-induced amplification of insulin secretion after glucose homeostatic dysregulation in healthy subjects.
    Hansen KB; Vilsbøll T; Bagger JI; Holst JJ; Knop FK
    J Clin Endocrinol Metab; 2012 Apr; 97(4):1363-70. PubMed ID: 22319034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of portal glucose sensing on incretin hormone secretion in a canine model.
    Edgerton DS; Kraft G; Smith MS; Moore LM; Farmer B; Scott M; Moore MC; Nauck MA; Cherrington AD
    Am J Physiol Endocrinol Metab; 2019 Aug; 317(2):E244-E249. PubMed ID: 31112407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic effect of portal glucose and glucagon-like peptide-1 to lower systemic glucose and stimulate counter-regulatory hormones.
    Ionut V; Hucking K; Liberty IF; Bergman RN
    Diabetologia; 2005 May; 48(5):967-75. PubMed ID: 15830188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.